Cargando…
Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
Piperacillin–tazobactam is one of the most common causes of drug‐induced immune hemolytic anemia (DIIHA) and is frequently utilized, especially in patients with cystic fibrosis (CF). Here, we report a case of life‐threatening piperacillin–tazobactam‐associated DIIHA in a 30‐year‐old woman with CF an...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715418/ https://www.ncbi.nlm.nih.gov/pubmed/29225856 http://dx.doi.org/10.1002/ccr3.1256 |